Drug Approval | March 21, 2023
Caplin receives USFDA approval for Rocuronium Bromide Injection
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Proposed combination enhances Pfizer’s position as a leading company in oncology
Subscribe To Our Newsletter & Stay Updated
